Document:

Exhibit 10.7

 

GEMINI
THERAPEUTICS, INC.

 

[FORM OF] OFFICER INDEMNIFICATION AGREEMENT

 

This Indemnification Agreement (“Agreement”)
is made as of [________________] by and between Gemini Therapeutics, Inc., a Delaware corporation (the “Company”),
and [Officer] (“Indemnitee”).

 

RECITALS

 

WHEREAS, the Company desires to attract
and retain the services of highly qualified individuals, such as Indemnitee, to serve the Company;

 

WHEREAS, in order to induce Indemnitee to
provide or continue to provide services to the Company, the Company wishes to provide for the indemnification of, and advancement
of expenses to, Indemnitee to the maximum extent permitted by law;

 

WHEREAS, the Amended and Restated Certificate
of Incorporation (as amended and in effect from time to time, the “Charter”) and the Amended and Restated Bylaws
(as amended and in effect from time to time, the “Bylaws”) of the Company require indemnification of the officers
and directors of the Company, and Indemnitee may also be entitled to indemnification pursuant to the General Corporation Law of
the State of Delaware (the “DGCL”);

 

WHEREAS, the Charter, the Bylaws and the
DGCL expressly provide that the indemnification provisions set forth therein are not exclusive, and thereby contemplate that contracts
may be entered into between the Company and members of the board of directors, officers and other persons with respect to indemnification;

 

WHEREAS, the Board of Directors of the Company
(the “Board”) has determined that the increased difficulty in attracting and retaining highly qualified persons
such as Indemnitee is detrimental to the best interests of the Company’s stockholders;

 

WHEREAS, it is reasonable and prudent for
the Company contractually to obligate itself to indemnify, and to advance expenses on behalf of, such persons to the fullest extent
permitted by applicable law, regardless of any amendment or revocation of the Charter or the Bylaws, so that they will serve or
continue to serve the Company free from undue concern that they will not be so indemnified; and

 

WHEREAS, this Agreement is a supplement
to and in furtherance of the indemnification provided in the Charter, the Bylaws and any resolutions adopted pursuant thereto,
and shall not be deemed a substitute therefor, nor to diminish or abrogate any rights of Indemnitee thereunder.

 

    

     

    

 

NOW, THEREFORE, in consideration of the
premises and the covenants contained herein, the Company and Indemnitee do hereby covenant and agree as follows:

 

Section 1.  Services to the Company.
Indemnitee agrees to [continue to] serve as [a director and] an officer of the Company. Indemnitee may at any time and for any
reason resign from [any] such position (subject to any other contractual obligation or any obligation imposed by law), in which
event the Company shall have no obligation under this Agreement to continue Indemnitee in such position. This Agreement shall not
be deemed an employment contract between the Company (or any of its subsidiaries or any Enterprise) and Indemnitee.

 

Section 2.  Definitions.

 

As used in this Agreement:

 

(a) “Change
in Control” shall mean (i) the sale of all or substantially all of the assets of the Company on a consolidated basis to an
unrelated person or entity, (ii) a merger, reorganization or consolidation pursuant to which the holders of the Company’s
outstanding voting power and outstanding stock immediately prior to such transaction do not own a majority of the outstanding voting
power and outstanding stock or other equity interests of the resulting or successor entity (or its ultimate parent, if applicable)
immediately upon completion of such transaction, (iii) the sale of all of the Stock of the Company to an unrelated person, entity
or group thereof acting in concert, or (iv) any other transaction in which the owners of the Company’s outstanding voting
power immediately prior to such transaction do not own at least a majority of the outstanding voting power of the Company or any
successor entity immediately upon completion of the transaction other than as a result of the acquisition of securities directly
from the Company.

 

(b) “Corporate
Status” describes the status of a person as a current or former [director or] officer of the Company or current or former
director, manager, partner, officer, employee, agent or trustee of any other Enterprise which such person is or was serving at
the request of the Company.

 

(c) “Enforcement
Expenses” shall include all reasonable attorneys’ fees, court costs, transcript costs, fees of experts, travel
expenses, duplicating costs, printing and binding costs, telephone charges, postage, delivery service fees, and all other out-of-pocket
disbursements or expenses of the types customarily incurred in connection with an action to enforce indemnification or advancement
rights, or an appeal from such action. Expenses, however, shall not include fees, salaries, wages or benefits owed to Indemnitee.

 

(d) “Enterprise”
shall mean any corporation (other than the Company), partnership, joint venture, trust, employee benefit plan, limited liability
company, or other legal entity of which Indemnitee is or was serving at the request of the Company as a director, manager, partner,
officer, employee, agent or trustee.

 

(e) “Expenses”
shall include all reasonable attorneys’ fees, court costs, transcript costs, fees of experts, travel expenses, duplicating
costs, printing and binding costs, telephone charges, postage, delivery service fees, and all other out-of-pocket disbursements
or expenses of the types customarily incurred in connection with prosecuting, defending, preparing to prosecute or defend, investigating,
being or preparing to be a witness in, or otherwise participating in, a Proceeding or an appeal resulting from a Proceeding. Expenses,
however, shall not include amounts paid in settlement by Indemnitee, the amount of judgments or fines against Indemnitee or fees,
salaries, wages or benefits owed to Indemnitee.

 

    2

     

    

 

(f) “Independent
Counsel” means a law firm, or a partner (or, if applicable, member or shareholder) of such a law firm, that is experienced
in matters of Delaware corporation law and neither presently is, nor in the past five (5) years has been, retained to represent:
(i) the Company, any subsidiary of the Company, any Enterprise or Indemnitee in any matter material to any such party; or (ii)
any other party to the Proceeding giving rise to a claim for indemnification hereunder. Notwithstanding the foregoing, the term
“Independent Counsel” shall not include any person who, under the applicable standards of professional conduct then
prevailing, would have a conflict of interest in representing either the Company or Indemnitee in an action to determine Indemnitee’s
rights under this Agreement. The Company agrees to pay the reasonable fees and expenses of the Independent Counsel referred to
above and to fully indemnify such counsel against any and all expenses, claims, liabilities and damages arising out of or relating
to this Agreement or its engagement pursuant hereto.

 

(g) The
term “Proceeding” shall include any threatened, pending or completed action, suit, arbitration, alternate dispute
resolution mechanism, investigation, inquiry, administrative hearing or any other actual, threatened or completed proceeding, whether
brought in the right of the Company or otherwise and whether of a civil, criminal, administrative, regulatory or investigative
nature, and whether formal or informal, in which Indemnitee was, is or will be involved as a party or otherwise by reason of the
fact that Indemnitee is or was [a director or] an officer of the Company or is or was serving at the request of the Company as
a director, manager, partner, officer, employee, agent or trustee of any Enterprise or by reason of any action taken by Indemnitee
or of any action taken on his or her part while acting as [a director or] an officer of the Company or while serving at the request
of the Company as a director, manager, partner, officer, employee, agent or trustee of any Enterprise, in each case whether or
not serving in such capacity at the time any liability or expense is incurred for which indemnification, reimbursement or advancement
of expenses can be provided under this Agreement; provided, however, that the term “Proceeding” shall
not include any action, suit or arbitration, or part thereof, initiated by Indemnitee to enforce Indemnitee’s rights under
this Agreement as provided for in Section 12(a) of this Agreement.

 

Section 3. Indemnity in Third-Party
Proceedings. The Company shall indemnify Indemnitee to the extent set forth in this Section 3 if Indemnitee is, or is threatened
to be made, a party to or a participant in any Proceeding, other than a Proceeding by or in the right of the Company to procure
a judgment in its favor. Pursuant to this Section 3, Indemnitee shall be indemnified against all Expenses, judgments, fines, penalties,
excise taxes, and amounts paid in settlement actually and reasonably incurred by Indemnitee or on his or her behalf in connection
with such Proceeding or any claim, issue or matter therein, if Indemnitee acted in good faith and in a manner he or she reasonably
believed to be in or not opposed to the best interests of the Company and, in the case of a criminal proceeding, had no reasonable
cause to believe that his or her conduct was unlawful.

 

Section 4. Indemnity in Proceedings
by or in the Right of the Company. The Company shall indemnify Indemnitee to the extent set forth in this Section 4 if Indemnitee
is, or is threatened to be made, a party to or a participant in any Proceeding by or in the right of the Company to procure a judgment
in its favor. Pursuant to this Section 4, Indemnitee shall be indemnified against all Expenses actually and reasonably incurred
by Indemnitee or on his or her behalf in connection with such Proceeding or any claim, issue or matter therein, if Indemnitee acted
in good faith and in a manner he or she reasonably believed to be in or not opposed to the best interests of the Company. No indemnification
for Expenses shall be made under this Section 4 in respect of any claim, issue or matter as to which Indemnitee shall have been
finally adjudged by a court to be liable to the Company, unless and only to the extent that the Delaware Court of Chancery (the
“Delaware Court”) shall determine upon application that, despite the adjudication of liability but in view of
all the circumstances of the case, Indemnitee is fairly and reasonably entitled to indemnification for such expenses as the Delaware
Court shall deem proper.

 

    3

     

    

 

Section 5. Indemnification for Expenses
of a Party Who is Wholly or Partly Successful. Notwithstanding any other provisions of this Agreement and except as provided
in Section 7, to the extent that Indemnitee is a party to or a participant in any Proceeding and is successful in such Proceeding
or in defense of any claim, issue or matter therein, the Company shall indemnify Indemnitee against all Expenses actually and reasonably
incurred by him or her in connection therewith. If Indemnitee is not wholly successful in such Proceeding but is successful as
to one or more but less than all claims, issues or matters in such Proceeding, the Company shall indemnify Indemnitee against all
Expenses actually and reasonably incurred by Indemnitee or on his or her behalf in connection with each successfully resolved claim,
issue or matter. For purposes of this Section and without limitation, the termination of any claim, issue or matter in such a Proceeding
by dismissal, with or without prejudice, shall be deemed to be a successful result as to such claim, issue or matter.

 

Section 6. Reimbursement for Expenses
of a Witness or in Response to a Subpoena. Notwithstanding any other provision of this Agreement, to the extent that Indemnitee,
by reason of his or her Corporate Status, (i) is a witness in any Proceeding to which Indemnitee is not a party and is not threatened
to be made a party or (ii) receives a subpoena with respect to any Proceeding to which Indemnitee is not a party and is not threatened
to be made a party, the Company shall reimburse Indemnitee for all Expenses actually and reasonably incurred by him or her or on
his or her behalf in connection therewith.

 

Section 7. Exclusions. Notwithstanding
any provision in this Agreement to the contrary, the Company shall not be obligated under this Agreement:

 

(a) to
indemnify for amounts otherwise indemnifiable hereunder (or for which advancement is provided hereunder) if and to the extent that
Indemnitee has otherwise actually received such amounts under any insurance policy, contract, agreement or otherwise;

 

(b) to
indemnify for an accounting of profits made from the purchase and sale (or sale and purchase) by Indemnitee of securities of the
Company within the meaning of Section 16(b) of the Securities Exchange Act of 1934, as amended, or similar provisions of state
statutory law or common law, or from the purchase or sale by Indemnitee of such securities in violation of Section 306 of the Sarbanes-Oxley
Act of 2002, as amended (“SOX”);

 

    4

     

    

 

(c) to
indemnify for any reimbursement of, or payment to, the Company by Indemnitee of any bonus or other incentive-based or equity-based
compensation or of any profits realized by Indemnitee from the sale of securities of the Company pursuant to Section 304 of SOX
or any formal policy of the Company adopted by the Board (or a committee thereof), or any other remuneration paid to Indemnitee
if it shall be determined by a final judgment or other final adjudication that such remuneration was in violation of law;

 

(d) to
indemnify with respect to any Proceeding, or part thereof, brought by Indemnitee against the Company, any legal entity which it
controls, any director or officer thereof or any third party, unless (i) the Board has consented to the initiation of such Proceeding
or part thereof and (ii) the Company provides the indemnification, in its sole discretion, pursuant to the powers vested in the
Company under applicable law; provided, however, that this Section 7(d) shall not apply to (A) counterclaims or affirmative
defenses asserted by Indemnitee in an action brought against Indemnitee or (B) any action brought by Indemnitee for indemnification
or advancement from the Company under this Agreement or under any directors’ and officers’ liability insurance policies
maintained by the Company in the suit for which indemnification or advancement is being sought as described in Section 12; or

 

(e) to
provide any indemnification or advancement of expenses that is prohibited by applicable law (as such law exists at the time payment
would otherwise be required pursuant to this Agreement).

 

Section 8. Advancement of Expenses.
Subject to Section 9(b), the Company shall advance, to the extent not prohibited by law, the Expenses incurred by Indemnitee in
connection with any Proceeding, and such advancement shall be made as incurred, and such advancement shall be made within thirty
(30) days after the receipt by the Company of a statement or statements requesting such advances (including any invoices received
by Indemnitee, which such invoices may be redacted as necessary to avoid the waiver of any privilege accorded by applicable law)
from time to time, whether prior to or after final disposition of any Proceeding. Advances shall be unsecured and interest free.
Advances shall be made without regard to Indemnitee’s (i) ability to repay the expenses, (ii) ultimate entitlement to indemnification
under the other provisions of this Agreement, and (iii) entitlement to and availability of insurance coverage, including advancement,
payment or reimbursement of defense costs, expenses of covered loss under the provisions of any applicable insurance policy (including,
without limitation, whether such advancement, payment or reimbursement is withheld, conditioned or delayed by the insurer(s)).
Indemnitee shall qualify for advances upon the execution and delivery to the Company of this Agreement which shall constitute an
undertaking providing that Indemnitee undertakes to the fullest extent required by law to repay the advance if and to the extent
that it is ultimately determined by a court of competent jurisdiction in a final judgment, not subject to appeal, that Indemnitee
is not entitled to be indemnified by the Company. The right to advances under this paragraph shall in all events continue until
final disposition of any Proceeding, including any appeal therein. Nothing in this Section 8 shall limit Indemnitee’s right
to advancement pursuant to Section 12(e) of this Agreement.

 

    5

     

    

 

Section 9. Procedure for Notification and Defense
of Claim.

 

(a) To
obtain indemnification under this Agreement, Indemnitee shall submit to the Company a written request therefor specifying the basis
for the claim, the amounts for which Indemnitee is seeking payment under this Agreement, and all documentation related thereto
as reasonably requested by the Company.

 

(b) In
the event that the Company shall be obligated hereunder to provide indemnification for or make any advancement of Expenses with
respect to any Proceeding, the Company shall be entitled to assume the defense of such Proceeding, or any claim, issue or matter
therein, with counsel approved by Indemnitee (which approval shall not be unreasonably withheld or delayed) upon the delivery to
Indemnitee of written notice of the Company’s election to do so. After delivery of such notice, approval of such counsel
by Indemnitee and the retention of such counsel by the Company, the Company will not be liable to Indemnitee under this Agreement
for any fees or expenses of separate counsel subsequently employed by or on behalf of Indemnitee with respect to the same Proceeding;
provided that (i) Indemnitee shall have the right to employ separate counsel in any such Proceeding at Indemnitee’s
expense and (ii) if (A) the employment of separate counsel by Indemnitee has been previously authorized by the Company, (B) Indemnitee
shall have reasonably concluded that there may be a conflict of interest between the Company and Indemnitee in the conduct of such
defense, or (C) the Company shall not continue to retain such counsel to defend such Proceeding, then the fees and expenses actually
and reasonably incurred by Indemnitee with respect to his or her separate counsel shall be Expenses hereunder.

 

(c)  In
the event that the Company does not assume the defense in a Proceeding pursuant to paragraph (b) above, then the Company will be
entitled to participate in the Proceeding at its own expense.

 

(d)  The
Company shall not be liable to indemnify Indemnitee under this Agreement for any amounts paid in settlement of any Proceeding effected
without its prior written consent (which consent shall not be unreasonably withheld or delayed). The Company shall not, without
the prior written consent of Indemnitee (which consent shall not be unreasonably withheld or delayed), enter into any settlement
which (i) includes an admission of fault of Indemnitee, any non-monetary remedy imposed on Indemnitee or any monetary damages for
which Indemnitee is not wholly and actually indemnified hereunder or (ii) with respect to any Proceeding with respect to which
Indemnitee may be or is made a party or may be otherwise entitled to seek indemnification hereunder, does not include the full
release of Indemnitee from all liability in respect of such Proceeding.

 

Section 10. Procedure Upon Application for Indemnification.

 

(a) Upon
written request by Indemnitee for indemnification pursuant to Section 9(a), a determination, if such determination is required
by applicable law, with respect to Indemnitee’s entitlement to indemnification hereunder shall be made in the specific case
by one of the following methods: [(x) if a Change in Control shall have occurred and indemnification is being requested by Indemnitee
hereunder in his or her capacity as a director of the Company, by Independent Counsel in a written opinion to the Board; or (y)
in any other case,] (i) by a majority vote of the disinterested directors, even though less than a quorum; (ii) by a committee
of disinterested directors designated by a majority vote of the disinterested directors, even though less than a quorum; or (iii)
if there are no disinterested directors or if the disinterested directors so direct, by Independent Counsel in a written opinion
to the Board. For purposes hereof, disinterested directors are those members of the Board who are not parties to the action, suit
or proceeding in respect of which indemnification is sought. In the case that such determination is made by Independent Counsel,
a copy of Independent Counsel’s written opinion shall be delivered to Indemnitee and, if it is so determined that Indemnitee
is entitled to indemnification, payment to Indemnitee shall be made within thirty (30) days after such determination. Indemnitee
shall cooperate with the Independent Counsel or the Company, as applicable, in making such determination with respect to Indemnitee’s
entitlement to indemnification, including providing to such counsel or the Company, upon reasonable advance request, any documentation
or information which is not privileged or otherwise protected from disclosure and which is reasonably available to Indemnitee and
reasonably necessary to such determination. Any out-of-pocket costs or expenses (including reasonable attorneys’ fees and
disbursements) actually and reasonably incurred by Indemnitee in so cooperating with the Independent Counsel or the Company shall
be borne by the Company (irrespective of the determination as to Indemnitee’s entitlement to indemnification) and the Company
hereby indemnifies and agrees to hold Indemnitee harmless therefrom.

 

    6

     

    

 

(b) If
the determination of entitlement to indemnification is to be made by Independent Counsel pursuant to Section 10(a), the Independent
Counsel shall be selected by the Board; provided that, if a Change in Control shall have occurred and indemnification is
being requested by Indemnitee hereunder in his or her capacity as a director of the Company, the Independent Counsel shall be selected
by Indemnitee. Indemnitee or the Company, as the case may be, may, within ten (10) days after written notice of such selection,
deliver to the Company or Indemnitee, as the case may be, a written objection to such selection; provided, however,
that such objection may be asserted only on the ground that the Independent Counsel so selected does not meet the requirements
of “Independent Counsel” as defined in Section 2 of this Agreement, and the objection shall set forth with particularity
the factual basis of such assertion. Absent a proper and timely objection, the person so selected shall act as Independent Counsel.
If such written objection is so made and substantiated, the Independent Counsel so selected may not serve as Independent Counsel
unless and until such objection is withdrawn or the Delaware Court has determined that such objection is without merit. If, within
twenty (20) days after the later of (i) submission by Indemnitee of a written request for indemnification pursuant to Section 9(a),
and (ii) the final disposition of the Proceeding, including any appeal therein, no Independent Counsel shall have been selected
without objection, either Indemnitee or the Company may petition the Delaware Court for resolution of any objection which shall
have been made by Indemnitee or the Company to the selection of Independent Counsel and/or for the appointment as Independent Counsel
of a person selected by the court or by such other person as the court shall designate. The person with respect to whom all objections
are so resolved or the person so appointed shall act as Independent Counsel under Section 10(a) hereof. Upon the due commencement
of any judicial proceeding or arbitration pursuant to Section 12(a) of this Agreement, Independent Counsel shall be discharged
and relieved of any further responsibility in such capacity (subject to the applicable standards of professional conduct then prevailing).

 

Section 11. Presumptions and Effect
of Certain Proceedings.

 

(a) To
the extent permitted by applicable law, in making a determination with respect to entitlement to indemnification hereunder, it
shall be presumed that Indemnitee is entitled to indemnification under this Agreement if Indemnitee has submitted a request for
indemnification in accordance with Section 9(a) of this Agreement, and the Company shall have the burden of proof to overcome that
presumption in connection with the making of any determination contrary to that presumption. Neither (i) the failure of the Company
or of Independent Counsel to have made a determination prior to the commencement of any action pursuant to this Agreement that
indemnification is proper in the circumstances because Indemnitee has met the applicable standard of conduct, nor (ii) an actual
determination by the Company or by Independent Counsel that Indemnitee has not met such applicable standard of conduct, shall be
a defense to the action or create a presumption that Indemnitee has not met the applicable standard of conduct.

 

(b) The
termination of any Proceeding or of any claim, issue or matter therein, by judgment, order, settlement or conviction, or upon a
plea of guilty, nolo contendere or its equivalent, shall not (except as otherwise expressly provided in this Agreement)
of itself adversely affect the right of Indemnitee to indemnification or create a presumption that Indemnitee did not act in good
faith and in a manner which he or she reasonably believed to be in or not opposed to the best interests of the Company or, with
respect to any criminal Proceeding, that Indemnitee had reasonable cause to believe that his or her conduct was unlawful.

 

(c) The
knowledge and/or actions, or failure to act, of any director, manager, partner, officer, employee, agent or trustee of the Company,
any subsidiary of the Company, or any Enterprise shall not be imputed to Indemnitee for purposes of determining the right to indemnification
under this Agreement.

 

    7

     

    

 

Section 12. Remedies of Indemnitee.

 

(a) Subject
to Section 12(f), in the event that (i) a determination is made pursuant to Section 10 of this Agreement that Indemnitee is not
entitled to indemnification under this Agreement, (ii) advancement of Expenses is not timely made pursuant to Section 8 of this
Agreement, (iii) no determination of entitlement to indemnification shall have been made pursuant to Section 10(a) of this Agreement
within sixty (60) days after receipt by the Company of the request for indemnification for which a determination is to be made
other than by Independent Counsel, (iv) payment of indemnification or reimbursement of expenses is not made pursuant to Section
5 or 6 or the last sentence of Section 10(a) of this Agreement within thirty (30) days after receipt by the Company of a written
request therefor (including any invoices received by Indemnitee, which such invoices may be redacted as necessary to avoid the
waiver of any privilege accorded by applicable law) or (v) payment of indemnification pursuant to Section 3 or 4 of this Agreement
is not made within thirty (30) days after a determination has been made that Indemnitee is entitled to indemnification, Indemnitee
shall be entitled to an adjudication by the Delaware Court of his or her entitlement to such indemnification or advancement. Alternatively,
Indemnitee, at his or her option, may seek an award in arbitration to be conducted by a single arbitrator pursuant to the Commercial
Arbitration Rules of the American Arbitration Association. Indemnitee shall commence such proceeding seeking an adjudication or
an award in arbitration within 180 days following the date on which Indemnitee first has the right to commence such proceeding
pursuant to this Section 12(a); provided, however, that the foregoing time limitation shall not apply in respect
of a proceeding brought by Indemnitee to enforce his or her rights under Section 5 of this Agreement. The Company shall not oppose
Indemnitee’s right to seek any such adjudication or award in arbitration.

 

(b) In
the event that a determination shall have been made pursuant to Section 10(a) of this Agreement that Indemnitee is not entitled
to indemnification, any judicial proceeding or arbitration commenced pursuant to this Section 12 shall be conducted in all respects
as a de novo trial, or arbitration, on the merits and Indemnitee shall not be prejudiced by reason of that adverse determination.
In any judicial proceeding or arbitration commenced pursuant to this Section 12, the Company shall have the burden of proving Indemnitee
is not entitled to indemnification or advancement, as the case may be.

 

(c)  If
a determination shall have been made pursuant to Section 10(a) of this Agreement that Indemnitee is entitled to indemnification,
the Company shall be bound by such determination in any judicial proceeding or arbitration commenced pursuant to this Section 12,
absent (i) a misstatement by Indemnitee of a material fact, or an omission of a material fact necessary to make Indemnitee’s
statement not materially misleading, in connection with the request for indemnification, or (ii) a prohibition of such indemnification
under applicable law.

 

(d) The
Company shall be precluded from asserting in any judicial proceeding or arbitration commenced pursuant to this Section 12 that
the procedures and presumptions of this Agreement are not valid, binding and enforceable and shall stipulate in any such court
or before any such arbitrator that the Company is bound by all the provisions of this Agreement.

 

(e) The
Company shall indemnify Indemnitee to the fullest extent permitted by law against any and all Enforcement Expenses and, if requested
by Indemnitee, shall (within thirty (30) days after receipt by the Company of a written request therefor) advance, to the extent
not prohibited by law, such Enforcement Expenses to Indemnitee, which are incurred by Indemnitee in connection with any action
brought by Indemnitee for indemnification or advancement from the Company under this Agreement or under any directors’ and
officers’ liability insurance policies maintained by the Company in the suit for which indemnification or advancement is
being sought. Such written request for advancement shall include invoices received by Indemnitee in connection with such Enforcement
Expenses but, in the case of invoices in connection with legal services, any references to legal work performed or to expenditures
made that would cause Indemnitee to waive any privilege accorded by applicable law need not be included with the invoice.

 

    8

     

    

 

(f) Notwithstanding
anything in this Agreement to the contrary, no determination as to entitlement to indemnification under this Agreement shall be
required to be made prior to the final disposition of the Proceeding, including any appeal therein.

 

Section 13. Non-exclusivity; Survival of Rights;
Insurance; Subrogation.

 

(a) The
rights of indemnification and to receive advancement as provided by this Agreement shall not be deemed exclusive of any other rights
to which Indemnitee may at any time be entitled under applicable law, the Charter, the Bylaws, any agreement, a vote of stockholders
or a resolution of directors, or otherwise. No amendment, alteration or repeal of this Agreement or of any provision hereof shall
limit or restrict any right of Indemnitee under this Agreement in respect of any action taken or omitted by such Indemnitee in
his or her Corporate Status prior to such amendment, alteration or repeal. To the extent that a change in Delaware law, whether
by statute or judicial decision, permits greater indemnification or advancement than would be afforded currently under the Charter,
Bylaws and this Agreement, it is the intent of the parties hereto that Indemnitee shall enjoy by this Agreement the greater benefits
so afforded by such change. No right or remedy herein conferred is intended to be exclusive of any other right or remedy, and every
other right and remedy shall be cumulative and in addition to every other right and remedy given hereunder or now or hereafter
existing at law or in equity or otherwise. The assertion or employment of any right or remedy hereunder, or otherwise, shall not
prevent the concurrent assertion or employment of any other right or remedy.

 

(b) To
the extent that the Company maintains an insurance policy or policies providing liability insurance for directors, managers, partners,
officers, employees, agents or trustees of the Company or of any other Enterprise, Indemnitee shall be covered by such policy or
policies in accordance with its or their terms to the maximum extent of the coverage available for any such director, manager,
partner, officer, employee, agent or trustee under such policy or policies. If, at the time of the receipt of a notice of a claim
pursuant to the terms hereof, the Company has director and officer liability insurance in effect, the Company shall give prompt
notice of the commencement of such proceeding to the insurers in accordance with the procedures set forth in the respective policies.
The Company shall thereafter take all necessary or desirable action to cause such insurers to pay, on behalf of Indemnitee, all
amounts payable as a result of such proceeding in accordance with the terms of such policies.

 

(c) In
the event of any payment under this Agreement, the Company shall be subrogated to the extent of such payment to all of the rights
of recovery of Indemnitee, who shall execute all papers required and take all action necessary to secure such rights, including
execution of such documents as are necessary to enable the Company to bring suit to enforce such rights.

 

(d) The
Company’s obligation to provide indemnification or advancement hereunder to Indemnitee who is or was serving at the request
of the Company as a director, manager, partner, officer, employee, agent or trustee of any other Enterprise shall be reduced by
any amount Indemnitee has actually received as indemnification or advancement from such other Enterprise.

 

Section 14.  Duration of Agreement.
This Agreement shall continue until and terminate upon the later of: (a) ten (10) years after the date that Indemnitee shall have
ceased to serve as [both a director and] an officer of the Company or (b) one (1) year after the final termination of any Proceeding,
including any appeal, then pending in respect of which Indemnitee is granted rights of indemnification or advancement hereunder
and of any proceeding commenced by Indemnitee pursuant to Section 12 of this Agreement relating thereto. This Agreement shall be
binding upon the Company and its successors and assigns and shall inure to the benefit of Indemnitee and his or her heirs, executors
and administrators. The Company shall require and cause any successor (whether direct or indirect by purchase, merger, consolidation
or otherwise) to all, substantially all or a substantial part, of the business and/or assets of the Company, by written agreement
in form and substance satisfactory to Indemnitee, expressly to assume and agree to perform this Agreement in the same manner and
to the same extent that the Company would be required to perform if no such succession had taken place.

 

    9

     

    

 

Section 15. Severability. If any
provision or provisions of this Agreement shall be held to be invalid, illegal or unenforceable for any reason whatsoever: (a)
the validity, legality and enforceability of the remaining provisions of this Agreement (including, without limitation, each portion
of any section of this Agreement containing any such provision held to be invalid, illegal or unenforceable, that is not itself
invalid, illegal or unenforceable) shall not in any way be affected or impaired thereby and shall remain enforceable to the fullest
extent permitted by law; (b) such provision or provisions shall be deemed reformed to the extent necessary to conform to applicable
law and to give the maximum effect to the intent of the parties hereto; and (c) to the fullest extent possible, the provisions
of this Agreement (including, without limitation, each portion of any section of this Agreement containing any such provision held
to be invalid, illegal or unenforceable, that is not itself invalid, illegal or unenforceable) shall be construed so as to give
effect to the intent manifested thereby.

 

Section 16. Enforcement.

 

(a) The
Company expressly confirms and agrees that it has entered into this Agreement and assumed the obligations imposed on it hereby
in order to induce Indemnitee to serve or continue to serve as [a director and] an officer of the Company, and the Company acknowledges
that Indemnitee is relying upon this Agreement in serving as [a director and] an officer of the Company.

 

(b) This
Agreement constitutes the entire agreement between the parties hereto with respect to the subject matter hereof and supersedes
all prior agreements and understandings, oral, written and implied, between the parties hereto with respect to the subject matter
hereof; provided, however, that this Agreement is a supplement to and in furtherance of the Charter, the Bylaws and
applicable law, and shall not be deemed a substitute therefor, nor to diminish or abrogate any rights of Indemnitee thereunder.

 

Section 17. Modification and Waiver.
No supplement, modification or amendment, or waiver of any provision, of this Agreement shall be binding unless executed in writing
by the parties thereto. No waiver of any of the provisions of this Agreement shall be deemed or shall constitute a waiver of any
other provisions of this Agreement nor shall any waiver constitute a continuing waiver. No supplement, modification or amendment
of this Agreement or of any provision hereof shall limit or restrict any right of Indemnitee under this Agreement in respect of
any action taken or omitted by such Indemnitee prior to such supplement, modification or amendment.

 

Section 18. Notice by Indemnitee.
Indemnitee agrees promptly to notify the Company in writing upon being served with any summons, citation, subpoena, complaint,
indictment, information or other document relating to any Proceeding or matter which may be subject to indemnification, reimbursement
or advancement as provided hereunder. The failure of Indemnitee to so notify the Company shall not relieve the Company of any obligation
which it may have to Indemnitee under this Agreement or otherwise.

 

Section 19. Notices. All notices,
requests, demands and other communications under this Agreement shall be in writing and shall be deemed to have been duly given
if (i) delivered by hand and receipted for by the party to whom said notice or other communication shall have been directed, (ii)
mailed by certified or registered mail with postage prepaid, on the third business day after the date on which it is so mailed,
(iii) mailed by reputable overnight courier and receipted for by the party to whom said notice or other communication shall have
been directed or (iv) sent by facsimile transmission, with receipt of oral confirmation that such transmission has been received:

 

(a) If
to Indemnitee, at such address as Indemnitee shall provide to the Company.

 

(b) If to the
Company to:

 

Gemini Therapeutics, Inc.

One Kendall Square, Building 300

Cambridge, MA 02139

Attention: Chief Executive Officer 

 

or to any other address as may have been furnished to Indemnitee
by the Company.

 

    10

     

    

 

Section 20. Contribution. To the
fullest extent permissible under applicable law, if the indemnification provided for in this Agreement is unavailable to Indemnitee
for any reason whatsoever, the Company, in lieu of indemnifying Indemnitee, shall contribute to the amount incurred by Indemnitee,
whether for judgments, fines, penalties, excise taxes, amounts paid or to be paid in settlement and/or for Expenses, in connection
with any Proceeding in such proportion as is deemed fair and reasonable in light of all of the circumstances in order to reflect
(i) the relative benefits received by the Company and Indemnitee in connection with the event(s) and/or transaction(s) giving rise
to such Proceeding; and/or (ii) the relative fault of the Company (and its directors, officers, employees and agents) and Indemnitee
in connection with such event(s) and/or transactions.

 

Section 21. Internal Revenue Code
Section 409A. The Company intends for this Agreement to comply with the Indemnification exception under Section 1.409A-1(b)(10)
of the regulations promulgated under the Internal Revenue Code of 1986, as amended (the “Code”), which provides
that indemnification of, or the purchase of an insurance policy providing for payments of, all or part of the expenses incurred
or damages paid or payable by Indemnitee with respect to a bona fide claim against Indemnitee or the Company do not provide for
a deferral of compensation, subject to Section 409A of the Code, where such claim is based on actions or failures to act by Indemnitee
in his or her capacity as a service provider of the Company. The parties intend that this Agreement be interpreted and construed
with such intent.

 

Section 22. Applicable Law and Consent
to Jurisdiction. This Agreement and the legal relations among the parties shall be governed by, and construed and enforced
in accordance with, the laws of the State of Delaware, without regard to its conflict of laws rules. Except with respect to any
arbitration commenced by Indemnitee pursuant to Section 12(a) of this Agreement, the Company and Indemnitee hereby irrevocably
and unconditionally (i) agree that any action or proceeding arising out of or in connection with this Agreement shall be brought
only in the Delaware Court, and not in any other state or federal court in the United States of America or any court in any other
country, (ii) consent to submit to the exclusive jurisdiction of the Delaware Court for purposes of any action or proceeding arising
out of or in connection with this Agreement, (iii) consent to service of process at the address set forth in Section 19 of this
Agreement with the same legal force and validity as if served upon such party personally within the State of Delaware, (iv) waive
any objection to the laying of venue of any such action or proceeding in the Delaware Court, and (v) waive, and agree not to plead
or to make, any claim that any such action or proceeding brought in the Delaware Court has been brought in an improper or inconvenient
forum.

 

Section 23. Headings. The headings
of the paragraphs of this Agreement are inserted for convenience only and shall not be deemed to constitute part of this Agreement
or to affect the construction thereof.

 

Section 24. Identical Counterparts.
This Agreement may be executed in one or more counterparts, each of which shall for all purposes be deemed to be an original but
all of which together shall constitute one and the same Agreement. Only one such counterpart signed by the party against whom enforceability
is sought needs to be produced to evidence the existence of this Agreement.

 

[Remainder of Page Intentionally Left Blank]

 

    11

     

    

 

IN WITNESS WHEREOF, the parties have caused
this Agreement to be signed as of the day and year first above written.

 

	 	GEMINI THERAPEUTICS, inc.
	 	  	 
	 	By:	
	 	Name:	                   
	 	Title:	 
	 	
	 	[Name of Indemnitee]

 

 

12Exhbiti 10.8

 

SUBSCRIPTION AGREEMENT

 

FS Development Corp.

600 Montgomery Street, Suite 4500

San Francisco, California 94111

Ladies and Gentlemen:

 

In connection with the
proposed business combination (the “Transaction”) between FS Development Corp., a Delaware corporation (“FSD”), and
Gemini Therapeutics, Inc., a Delaware corporation (“Target”), pursuant to a merger agreement to be entered into
among FSD, Target, and the other parties thereto (the “Transaction Agreement”), FSD is seeking commitments from
interested investors to purchase shares of Class A common stock, par value $0.0001 per share (the “Shares”),
of FSD, for a purchase price of $10.00 per share (the “Per Share Purchase Price”). The aggregate purchase price
to be paid by the undersigned (the “Investor”) for the subscribed Shares (as set forth on the signature page
hereto) is referred to herein as the “Subscription Amount.” On or about the date of this Subscription Agreement,
FSD is entering into subscription agreements (the “Other Subscription Agreements” and together with this Subscription
Agreement, the “Subscription Agreements”) with certain other investors (the “Other Investors”
and together with the Investor, the “Investors”), severally and not jointly, pursuant to which the Investors,
severally and not jointly, have agreed to purchase on the closing date of the Transaction, inclusive of the Shares subscribed for
by the Investor, an aggregate amount of up to 9,500,000 Shares, at a per share price equal to the Per Share Purchase Price.

 

In connection therewith,
and in consideration of the foregoing and the mutual representations, warranties and covenants, and subject to the conditions,
set forth herein, and intending to be legally bound hereby, the Investor and FSD agree as follows:

 

1. Subscription.
The Investor hereby subscribes for and agrees to purchase from FSD at the Closing (as defined herein) the number of Shares set
forth on the signature page of this Subscription Agreement on the terms and subject to the conditions provided for herein.

 

2. Closing.
The closing of the sale of the Shares contemplated hereby (the “Closing”) is contingent upon the substantially
concurrent consummation of the Transaction. The Closing shall occur on the date of, and substantially concurrently with and conditioned
upon the effectiveness of the Transaction and immediately after the Merger (as defined in the Transaction Agreement). Upon (i)
satisfaction or waiver of the conditions set forth in this Section 2 and Section 3 of this Subscription Agreement
and (ii) delivery of written notice from (or on behalf of) FSD to the Investor (the “Closing Notice”) that FSD
reasonably expects all conditions to the closing of the Transaction to be satisfied or waived on a date that is not less than five
(5) business days from the date on which the Closing Notice is delivered to the undersigned (the “Closing Date”),
the Investor shall deliver to FSD on the Closing Date the Subscription Amount by wire transfer of United States dollars in immediately
available funds to the account(s) specified by FSD in the Closing Notice (which account shall not be an escrow account) against
delivery by FSD to the Investor on the Closing Date (A) the number of Shares set forth on the signature page of this Subscription
Agreement in book entry form, free and clear of any liens or other restrictions (other than those arising under applicable securities
laws), in the name of the Investor (or its nominee in accordance with its delivery instructions) or to a custodian designated by
the Investor, as applicable, and (B) evidence from FSD’s transfer agent evidencing the issuance to the Investor of such Shares
on and as of the Closing Date. If the closing of the Transaction does not occur within two (2) Business Days after the Closing
Date, FSD shall promptly (but not later than two (2) Business Days after the Closing Date) return the funds so delivered by the
Investor to FSD by wire transfer in immediately available funds to the account specified by the Investor. For purposes of this
Subscription Agreement, “business day” shall mean any day other than (a) any Saturday or Sunday or (b) any other day
on which commercial banks in New York, New York and Boston, Massachusetts are open for the general transaction of business.

 

     

     

    

 

3. Closing
Conditions.

 

a. The
obligation of the parties hereto to consummate the purchase and sale of the Shares pursuant to this Subscription Agreement is subject
to the following conditions:

 

(i) no
applicable governmental authority shall have enacted, issued, promulgated, enforced or entered any judgment, order, law, rule or
regulation (whether temporary, preliminary or permanent) which is then in effect and has the effect of making consummation of the
transactions contemplated hereby illegal or otherwise restraining or prohibiting consummation of the transactions contemplated
hereby;

 

(ii) no
suspension of the qualification of the Shares for the offering or sale or trading on the Nasdaq Capital Market, or, to FSD’s
knowledge, initiation or threatening of any proceedings for any of such purposes, shall have occurred prior to the Closing;

 

(iii) all
conditions precedent to the closing of the Transaction shall have been satisfied (as determined by the parties to the Transaction
Agreement) or waived (other than those conditions which, by their nature, are to be satisfied at the closing of the Transaction);
and

 

(iv) the Shares
shall have been approved for listing on the Nasdaq Capital Market.

 

b. The
obligation of FSD to consummate the issuance and sale of the Shares pursuant to this Subscription Agreement shall be subject to
the condition that all representations and warranties of the Investor contained in this Subscription Agreement are true and correct
in all material respects (other than representations and warranties that are qualified as to materiality or Material Adverse Effect,
which representations and warranties shall be true in all respects), at and as of the Closing Date, and consummation of the Closing
shall constitute a reaffirmation by the Investor of each of the representations warranties, covenants and agreements of the Investor
contained in this Subscription Agreement as of the Closing Date.

 

c. The
obligation of the Investor to consummate the purchase of the Shares pursuant to this Subscription Agreement shall be subject to
the following conditions:

 

(i) all
representations and warranties of FSD contained in this Subscription Agreement shall be true and correct in all material respects
(other than representations and warranties that are qualified as to materiality or Material Adverse Effect (as defined herein),
which representations and warranties shall be true in all respects) at and as of the Closing Date, and consummation of the Closing
shall constitute a reaffirmation by FSD of each of the representations and warranties of FSD contained in this Subscription Agreement
as of the Closing Date;

 

(ii) FSD
shall have performed, satisfied and complied in all material respects with all covenants, agreements and conditions required by
this Subscription Agreement to be performed, satisfied or complied with by it at or prior to the Closing;

 

(iii) the
terms of the Transaction Agreement shall not have been amended in a manner that would reasonably be expected to materially and
adversely affect the economic benefits that the Investor or FSD would reasonably expect to receive under this Subscription Agreement;
and

 

(iv) there
shall have been no amendment, waiver or modification to the Other Subscription Agreements that materially economically benefits
the Other Investors thereunder unless the Investor has been offered substantially the same benefits.

 

4. Further
Assurances. At the Closing, the parties hereto shall execute and deliver such additional documents and take such additional
actions as the parties reasonably may deem to be practical and necessary in order to consummate the subscription as contemplated
by this Subscription Agreement.

 

5. FSD
Representations and Warranties. FSD represents and warrants to the Investor, as of the date hereof and as of the Closing Date
that:

 

a. FSD
has been duly incorporated, validly existing and in good standing under the laws of the State of Delaware, with corporate power
and authority to own, lease and operate its properties and conduct its business as presently conducted and to enter into, deliver
and perform its obligations under this Subscription Agreement.

 

    2

     

    

 

b. As
of the Closing Date, the Shares will be duly authorized and, when issued and delivered to the Investor against full payment therefor
in accordance with the terms of this Subscription Agreement, the Shares will be validly issued, fully paid and non-assessable and
will not have been issued in violation of or subject to any preemptive or similar rights created under FSD’s certificate
of incorporation (as amended to the Closing Date) or under the laws of the State of Delaware.

 

c. This
Subscription Agreement has been duly authorized, executed and delivered by FSD and, assuming that this Subscription Agreement constitutes
the valid and binding agreement of the Investor, this Subscription Agreement constitutes the valid and binding agreement of FSD
and is enforceable against FSD in accordance with its terms, except as may be limited or otherwise affected by bankruptcy, insolvency,
fraudulent conveyance, reorganization, moratorium or other similar laws affecting the enforcement of creditors’ rights generally
and by general principles of equity.

 

d. The
execution and delivery of this Subscription Agreement, the issuance and sale of the Shares and the compliance by FSD with all of
the provisions of this Subscription Agreement and the consummation of the transactions contemplated herein will not conflict with
or result in a breach or violation of any of the terms or provisions of, or constitute a default under, or result in the creation
or imposition of any lien, charge or encumbrance upon any of the property or assets of FSD or any of its subsidiaries pursuant
to the terms of (i) any indenture, mortgage, deed of trust, loan agreement, lease, license or other agreement or instrument to
which FSD or any of its subsidiaries is a party or by which FSD or any of its subsidiaries is bound or to which any of the property
or assets of FSD is subject that would reasonably be expected to have a material adverse effect on the business, financial condition
or results of operations of FSD and its subsidiaries, taken as a whole or materially and adversely affect: (A) the ability of FSD
to consummate the Transaction; (B) the validity of the Shares; or (C) the legal authority of FSD to comply in all material respects
with the terms of this Subscription Agreement (a “Material Adverse Effect”); (ii) result in any violation of
the provisions of the organizational documents of FSD; or (iii) result in any violation of any statute or any judgment, order,
rule or regulation of any court or governmental agency or body, domestic or foreign, having jurisdiction over FSD or any of their
properties that would reasonably be expected to have a Material Adverse Effect or materially affect the validity of the Shares
or the legal authority of FSD to comply in all material respects with this Subscription Agreement.

 

e. FSD
has made all filings required to be filed by it with the U.S. Securities and Exchange Commission (the “SEC”).
As of their respective dates, all reports, the Registration Statement of FSD filed on Form S-1 dated July 24, 2020 (as amended),
and the prospectus of FSD dated August 11, 2020 (the “SEC Reports”) required to be filed or actually filed by
FSD with the SEC complied in all material respects with the applicable requirements of the Securities Act of 1933, as amended,
(the “Securities Act”) and the Securities Exchange Act of 1934, as amended (the “Exchange Act”)
and the rules and regulations of the SEC promulgated thereunder, and none of the SEC Reports, when filed, contained any untrue
statement of a material fact or omitted to state a material fact required to be stated therein or necessary in order to make the
statements therein, in the light of the circumstances under which they were made, not misleading. The financial statements
of FSD included in the SEC Reports comply in all material respects with applicable accounting requirements and the rules and regulations
of the SEC with respect thereto as in effect at the time of filing and fairly present in all material respects the financial condition
of FSD as of and for the dates thereof and the results of operations and cash flows for the periods then ended, subject, in the
case of unaudited statements, to normal, year-end audit adjustments. A copy of each SEC Report is available to the Investor via
the SEC’s EDGAR system. There are no outstanding or unresolved comments in comment letters received by FSD from the staff
of the Division of Corporation Finance of the SEC with respect to any of the SEC Reports.

 

f. FSD
has not entered into any side letter or similar agreement with any Other Investor or any other investor in connection with such
Other Investor’s or other investor’s direct or indirect investment in FSD other than the Other Subscription Agreement
and the Transaction Agreement. No Other Subscription Agreement contains terms (economic or otherwise) more favorable to such Other
Investor or investor than as set forth in this Subscription Agreement. The Other Subscription Agreements have not been amended
in any material respect following the date of this Subscription Agreement.

 

g. FSD is not
required to obtain any consent, waiver, authorization or order of, give any notice to, or make any filing or registration
with, any court or other federal, state, local or other governmental authority, self-regulatory organization or other person
in connection with the execution, delivery and performance by FSD of this Subscription Agreement (including, without
limitation, the issuance of the Shares), other than (i) filings with the SEC, (ii) filings required by applicable state
securities laws, (iii) filings required by The Nasdaq Capital Market, or such other applicable stock exchange on which
FSD’s Class A common stock is then listed (the “Stock Exchange”), and (iv) the failure of which to
obtain would not be reasonably likely to have, individually or in the aggregate, a Material Adverse Effect. FSD is in
compliance with all applicable laws and rules of The Nasdaq Capital Market.

 

    3

     

    

 

h. The
authorized capital stock of FSD consists of 100,000,000 Shares of which 12,516,500 are outstanding, 10,000,000 shares of Class
B common stock, par value $0.0001 per share of which 3,018,750 are issued and outstanding, and 1,000,000 shares of preferred stock,
par value $0.0001 per share, none of which are issued and outstanding. No other shares of capital stock or other voting securities
of FSD are issued, reserved for issuance or outstanding. All issued and outstanding Shares are duly authorized, validly issued,
fully paid and nonassessable and not subject to or issued in violation of any purchase option, right of first refusal, preemptive
right, subscription right or any similar right under any provision of the Delaware General Corporation Law, FSD’s organizational
documents or any contract to which FSD is a party or by which FSD is bound. Except as set forth in FSD’s organizational documents,
there are no outstanding contractual obligations of FSD to repurchase, redeem or otherwise acquire any Shares or any capital equity
of FSD. There are no securities or instruments issued by or to which FSD is a party containing anti-dilution or similar provisions
that will be triggered by the issuance of (i) the Shares pursuant to this Subscription Agreement or (ii) the shares to be issued
pursuant to any Other Subscription Agreement. There are no outstanding contractual obligations of FSD to provide funds to, or make
any investment (in the form of a loan, capital contribution or otherwise) in, any other person or entity.

 

i. The
issued and outstanding Shares are registered pursuant to Section 12(b) of the Exchange Act, and are listed for trading on the Stock
Exchange. There is no suit, action, proceeding or investigation pending or, to the knowledge of FSD, threatened against FSD by
Nasdaq or the SEC to deregister the Shares or prohibit or terminate the listing of the Shares on Nasdaq. FSD has taken no action
that is designed to terminate the registration of the Shares under the Exchange Act.

 

j. Assuming
the accuracy of the Investor’s representations and warranties set forth in Section 6, no registration under the Securities
Act is required for the offer and sale of the Shares by FSD to the Investor hereunder. The Shares (i) were not offered by any form
of general solicitation or general advertising and (ii) are not being offered in a manner involving a public offering under, or
in a distribution in violation of, the Securities Act, or any state securities laws.

 

k. Except
for such matters as have not had and would not be reasonably likely to have, individually or in the aggregate, a Material Adverse
Effect, there is no (i) action, suit, claim or other proceeding, in each case by or before any governmental authority pending,
or, to the knowledge of FSD, threatened against FSD or (ii) judgment, decree, injunction, ruling or order of any governmental entity
or arbitrator outstanding against FSD.

 

l. FSD
has not received any written communication from a governmental authority that alleges that FSD is not in compliance with or is
in default or violation of any applicable law, except where such non-compliance, default or violation would not reasonably be expected
to have a Material Adverse Effect.

 

m. FSD
is not under any obligation to pay any broker’s fee or commission in connection with the sale of the Shares hereunder other
than to the Placement Agents (as defined herein).

 

n. FSD
acknowledges and agrees that, notwithstanding anything herein to the contrary, the Shares may be pledged by Investor in connection
with a bona fide margin agreement, which shall not be deemed to be a transfer, sale or assignment of the Shares hereunder, and
the Investor effecting a pledge of Shares shall not be required to provide FSD with any notice thereof or otherwise make any delivery
to the Investor pursuant to this Agreement. The Investor hereby agrees to execute and deliver such documentation as a pledgee of
the Shares may reasonably request in connection with a pledge of the Shares to such pledgee by the Investor.

 

6. Investor
Representations and Warranties. The Investor represents and warrants to FSD that:

 

a. The Investor
(i) is a “qualified institutional buyer” (as defined in Rule 144A under the Securities Act), an institutional
“accredited investor” or an “accredited investor” (within the meaning of Rule 501(a) under the
Securities Act), in each case, satisfying the applicable requirements set forth on Schedule A,(ii) is an
“institutional account” (as defined in FINRA Rule 4512(c)), (iii) is not an underwriter (as defined in Section
2(a)(11) of the Securities Act) and is acquiring the Shares only for his, her or its own account and not for the account of
others, or if the undersigned is subscribing for the Shares as a fiduciary or agent for one or more investor accounts, the
Investor has full investment discretion with respect to each such account, and the full power and authority to make the
acknowledgements, representations and agreements herein on behalf of each owner of each such account, and (iv) is not
acquiring the Shares with a view to, or for offer or sale in connection with, any distribution thereof in violation of the
Securities Act (and shall provide the requested information on Schedule A). The Investor is not an entity formed
for the specific purpose of acquiring the Shares.

 

    4

     

    

 

b. The
Investor understands that the Shares are being offered in a transaction not involving any public offering within the meaning of
the Securities Act and that the Shares have not been registered under the Securities Act. The Investor understands that the Shares
may not be resold, transferred, pledged or otherwise disposed of by the Investor absent an effective registration statement under
the Securities Act except (i) to FSD or a subsidiary thereof, (ii) to non-U.S. persons pursuant to offers and sales that occur
outside the United States within the meaning of Regulation S under the Securities Act or (iii) pursuant to another applicable exemption
from the registration requirements of the Securities Act, and in each of cases (i) and (iii) in accordance with any applicable
securities laws of the states and other jurisdictions of the United States, and that any certificates representing the Shares shall
contain a restrictive legend to such effect. The Investor acknowledges that the Shares will not be eligible for resale pursuant
to Rule 144A promulgated under the Securities Act. The Investor acknowledges and agrees that the Shares will not be eligible for
offer, resale, transfer, pledge or disposition pursuant to Rule 144 promulgated under the Securities Act until at least one year
from the date that FSD files a Current Report on Form 8-K following the Closing Date that includes the “Form 10” information
required under applicable SEC rules and regulations. The Investor understands that it has been advised to consult legal counsel
prior to making any offer, resale, transfer, pledge or disposition of any of the Shares.

 

c. The
Investor understands and agrees that the Investor is purchasing the Shares from FSD. The Investor further acknowledges that there
have been no representations, warranties, covenants and agreements made to the Investor by FSD, Target or their respective officers
or directors, expressly or by implication, other than those representations, warranties, covenants and agreements included in this
Subscription Agreement.

 

d. The
Investor’s acquisition and holding of the Shares will not constitute or result in a non-exempt prohibited transaction under
Section 406 of the Employee Retirement Income Security Act of 1974, as amended, Section 4975 of the Internal Revenue Code of 1986,
as amended, or any applicable similar law.

 

e. The
Investor acknowledges and agrees that the Investor has received such information as the Investor deems necessary in order to make
an investment decision with respect to the Shares, including with respect to FSD, Target or the Transaction. Without limiting the
generality of the foregoing, the Investor acknowledges that he, she or it has carefully reviewed the SEC Reports and any disclosure
documents used in the offering of the Shares. The Investor represents and agrees that the Investor and the Investor’s professional
advisor(s), if any (i) have had the full opportunity to ask such questions, receive such answers and obtain such information as
the Investor and such Investor’s professional advisor(s), if any, have deemed necessary to make an investment decision with
respect to the Shares and (ii) have independently made their own analysis and decision to invest in FSD.

 

f. The
Investor became aware of this offering of the Shares solely by means of direct contact between the Investor and FSD, Target, or
a representative of FSD or Target, and the Shares were offered to the Investor solely by direct contact between the Investor and
FSD, Target, or a representative of FSD or Target. The Investor did not become aware of this offering of the Shares, nor were the
Shares offered to the Investor, by any other means. The Investor acknowledges that the Shares (i) were not offered by any form
of general solicitation or general advertising and (ii) are not being offered in a manner involving a public offering under, or
in a distribution in violation of, the Securities Act, or any state securities laws. Investor acknowledges that it is not relying
upon, and has not relied upon, any statement, representation or warranty made by any person, firm or corporation (including, without
limitation, Target, FSD, Jefferies LLC or SVB Leerink LLC (each a “Placement Agent”, and together,
the “Placement Agents”) or their respective affiliates or any of their or their respective affiliates’
control persons, officers, directors, employees or representatives), other than the representations and warranties of FSD contained
in Section 5 of this Subscription Agreement, in making its investment or decision to invest in FSD.

 

g. The
Investor acknowledges that it is aware that there are substantial risks incident to the purchase and ownership of the Shares, including
those set forth in FSD’s filings with the SEC. The Investor has such knowledge and experience in financial and business matters
as to be capable of evaluating the merits and risks of an investment in the Shares, and the Investor has sought such accounting,
legal and tax advice as the Investor has considered necessary to make an informed investment decision.

 

    5

     

    

 

h. Alone,
or together with any professional advisor(s), the Investor has adequately analyzed and fully considered the risks of an investment
in the Shares and determined that the Shares are a suitable investment for the Investor and that the Investor is able at this time
and in the foreseeable future to bear the economic risk of a total loss of the Investor’s investment in FSD.

i. In
making its decision to purchase the Shares, the Investor has relied solely upon independent investigation made by the Investor.
Without limiting the generality of the foregoing, the Investor has not relied on any statements or other information provided by
or on behalf of the Placement Agents or any of their respective affiliates or any of their or their respective affiliates’
control persons, officers, directors, employees or representatives concerning FSD, Target, the Transaction, the Transaction Agreement,
this Subscription Agreement or the transactions contemplated hereby or thereby, the Shares or the offer and sale of the Shares.

 

j. The
Investor understands and agrees that no federal or state agency has passed upon or endorsed the merits of the offering of the Shares
or made any findings or determination as to the fairness of this investment.

 

k. The
Investor has been duly formed or incorporated and is validly existing in good standing under the laws of its jurisdiction of incorporation
or formation, with power and authority to enter into, deliver and perform its obligations under this Subscription Agreement.

 

l. The
execution, delivery and performance by the undersigned of this Subscription Agreement are within the powers of the Investor, have
been duly authorized and will not constitute or result in a breach or default under or conflict with any order, ruling or regulation
of any court or other tribunal or of any governmental commission or agency, or any agreement or other undertaking, to which the
undersigned is a party or by which the undersigned is bound, and, if the undersigned is not an individual, will not violate any
provisions of the undersigned’s charter documents, including, without limitation, its incorporation or formation papers,
bylaws, indenture of trust or partnership or operating agreement, as may be applicable. The signature of the Investor on this Subscription
Agreement is genuine, and the signatory, if the Investor is an individual, has legal competence and capacity to execute the same
or, if the Investor is not an individual, the signatory has been duly authorized to execute the same, and assuming that this Subscription
Agreement constitutes the valid and binding obligation of FSD, this Subscription Agreement constitutes a legal, valid and binding
obligation of the Investor, enforceable against the undersigned in accordance with its terms except as may be limited or otherwise
affected by bankruptcy, insolvency, reorganization or other similar laws affecting the enforcement of creditors’ rights generally
and by general principles of equity.

 

m. The
undersigned is not (i) a person or entity named on the List of Specially Designated Nationals and Blocked Persons administered
by the U.S. Treasury Department’s Office of Foreign Assets Control (“OFAC”) or in any Executive Order
issued by the President of the United States and administered by OFAC (“OFAC List”), or a person or entity prohibited
by any OFAC sanctions program, (ii) a Designated National as defined in the Cuban Assets Control Regulations, 31 C.F.R. Part 515,
or (iii) a non-U.S. shell bank or providing banking services indirectly to a non-U.S. shell bank (collectively, a “Prohibited
Investor”). The Investor agrees to provide law enforcement agencies, if requested thereby, such records as required by
applicable law, provided that the Investor is permitted to do so under applicable law. If the Investor is a financial institution
subject to the Bank Secrecy Act (31 U.S.C. Section 5311 et seq.) (the “BSA”), as amended by the USA PATRIOT Act of
2001 (the “PATRIOT Act”), and its implementing regulations (collectively, the “BSA/PATRIOT Act”),
the Investor maintains policies and procedures reasonably designed to comply with applicable obligations under the BSA/PATRIOT
Act. To the extent required, it maintains policies and procedures reasonably designed for the screening of its investors against
the OFAC sanctions programs, including the OFAC List. To the extent required by applicable law, the Investor maintains policies
and procedures reasonably designed to ensure that the funds held by the Investor and used to purchase the Shares were legally derived.

 

n. No
disclosure or offering document has been prepared by either of the Placement Agents or any of their respective affiliates in connection
with the offer and sale of the Shares.

 

o. Neither
the Placement Agents nor any of their respective directors, officers, employees, representatives and controlling persons have made
any independent investigation with respect to FSD or the Shares or the accuracy, completeness or adequacy of any information supplied
to the Investor by FSD.

 

p. In
connection with the issue and purchase of the Shares, the Placement Agents have not acted as the Investor’s financial advisor
or fiduciary.

 

    6

     

    

 

q. When
required to deliver payment to FSD pursuant to Section 2 above, the Investor will have sufficient funds to pay the Subscription
Amount and consummate the purchase and sale of the Shares pursuant to this Subscription Agreement.

 

r. The
Investor acknowledges that it is aware that the Placement Agents are acting as FSD’s placement agents or financial advisors
and certain of the Placement Agents are acting as financial advisor to Target in connection with the Transaction.

 

7. Registration
Rights.

 

a. In
the event that the Shares are not registered in connection with the consummation of the Transaction, FSD agrees that, within thirty
(30) calendar days after the consummation of the Transaction (the “Filing Deadline”), it will file with the
SEC (at the its sole cost and expense) a registration statement registering the resale of such Shares (the “Registration
Statement”), and it shall use its commercially reasonable efforts to have the Registration Statement declared effective
as soon as practicable after the filing thereof, but no later than the earlier of (1) the 90th calendar day after the consummation
of the Transaction (or 120th calendar day if the SEC notifies FSD that it will “review” the Registration
Statement) and (2) the fifth business day after the date FSD is notified in writing by the SEC that the Registration Statement
will not be “reviewed” or will not be subject to further review (the “Effectiveness Date”). FSD
agrees to cause such Registration Statement, or another shelf registration statement that includes the Shares to be sold pursuant
to this Subscription Agreement, to remain effective, except for such times as FSD is permitted hereunder to suspend the use of
the prospectus forming part of the Registration Statement, until the earliest of (i) the third anniversary of the Closing, (ii)
the date on which the Investor ceases to hold any Shares issued pursuant to this Subscription Agreement, or (iii) on the first
date on which the Investor can sell all of its Shares issued pursuant to this Subscription Agreement (or shares received in exchange
therefor) under Rule 144 of the Securities Act without volume or manner of sale limitations and without the requirement for FSD
to be in compliance with the current public information required under Rule 144(c)(2) (or Rule 144(i)(2), if applicable). The Investor
agrees to disclose its beneficial ownership as determined in accordance with Rule 13d-3 of the Exchange Act to FSD upon request
to assist it in making the determination described above. In no event shall the Investor be identified as a statutory underwriter
in the Registration Statement unless requested by the SEC; provided, that if the SEC requests that the Investor be
identified as a statutory underwriter in the Registration Statement, the Investor will have an opportunity to withdraw its Shares
from the Registration Statement. Notwithstanding the foregoing, if the SEC prevents FSD from including any or all of the shares
proposed to be registered under the Registration Statement due to limitations on the use of Rule 415 of the Securities Act for
the resale of the Shares by the applicable shareholders or otherwise, such Registration Statement shall register for resale such
number of Shares which is equal to the maximum number of Shares as is permitted by the SEC. In such event, the number of Shares
to be registered for each selling shareholder named in the Registration Statement shall be reduced pro rata among all such selling
shareholders. FSD’s obligations to include the Shares issued pursuant to this Subscription Agreement (or shares issued in
exchange therefor) for resale in the Registration Statement are contingent upon the Investor furnishing in writing to FSD such
information regarding the Investor, the securities of FSD held by the Investor and the intended method of disposition of such Shares
as shall be reasonably requested by FSD to effect the registration of such Shares, and shall execute such documents in connection
with such registration as FSD may reasonably request that are customary of a selling stockholder in similar situations, including
providing that FSD shall be entitled to postpone and suspend the effectiveness or use of the Registration Statement during any
customary blackout period or similar period or as permitted hereunder. Investor shall not be entitled to use the Registration Statement
for an underwritten offering. For purposes of clarification, any failure by FSD to file the Registration Statement by the Filing
Deadline or to effect such Registration Statement by the Effectiveness Date shall not otherwise relieve FSD of its obligations
to file or effect the Registration Statement set forth in this Section 7. For as long as the Registration Statement shall remain
effective pursuant to this Section 7(a), FSD will use commercially reasonable efforts to (1) qualify the Shares for listing on
the Stock Exchange, and (2) update or amend the Registration Statement as necessary to include the Shares. For as long as the Investor
holds the Shares, FSD will use commercially reasonable efforts to (A) make and keep public information available, as those terms
are understood and defined in Rule 144, (B) file in a timely manner all reports and other documents with the SEC required under
the Exchange Act, as long as FSD remains subject to such requirements, and (C) provide all customary and reasonable cooperation
necessary, in each case, to enable the undersigned to resell the Shares pursuant to the Registration Statement or Rule 144 of the
Securities Act (when Rule 144 of the Securities Act becomes available to the Investor), as applicable.

 

    7

     

    

 

b. Notwithstanding
anything to the contrary contained herein, FSD may delay or postpone filing of such Registration Statement, and from time to time
require the Investor not to sell under the Registration Statement or suspend the use or effectiveness of any such Registration
Statement, if the board of directors of FSD determines in good faith that either in order for the Registration Statement to not
contain a material misstatement or omission, an amendment thereto would be needed, or if such filing or use could materially affect
a bona fide business or financing transaction of FSD or would require premature disclosure of information that could materially
adversely affect FSD (each such circumstance, a “Suspension Event”); provided, that, (I) FSD shall not so delay
filing or so suspend the use of the Registration Statement on more than two (2) occasions or for a period of more than ninety (90)
consecutive days or more than a total of one hundred-twenty (120) calendar days, in each case in any three hundred sixty (360)
day period and (II) FSD shall use commercially reasonable efforts to make such Registration Statement available for the sale by
the undersigned of such securities as soon as practicable thereafter. If so directed by FSD, the Investor will deliver to FSD or,
in the Investor’s sole discretion destroy, all copies of the prospectus covering the Shares in the Investor’s possession; provided, however,
that this obligation to deliver or destroy all copies of the prospectus covering the Shares shall not apply (i) to the extent the
Investor is required to retain a copy of such prospectus (A) in order to comply with applicable legal or regulatory requirements
or (B) in accordance with a bona fide pre-existing document retention policy or (ii) to copies stored electronically on archival
servers as a result of automatic data back-up.

 

c. At
its expense FSD shall advise the Investor within two (2) business days: (i) when a Registration Statement or any post-effective
amendment thereto has become effective; (ii) of the issuance by the SEC of any stop order suspending the effectiveness of
any Registration Statement or the initiation of any proceedings for such purpose; (iii) of the receipt by FSD of any notification
with respect to the suspension of the qualification of the Shares included therein for sale in any jurisdiction or the initiation
or threatening of any proceeding for such purpose; and (iv) subject to the provisions in this Subscription Agreement, of the
occurrence of any event that requires the making of any changes in any Registration Statement or prospectus so that, as of such
date, the statements therein are not misleading and do not omit to state a material fact required to be stated therein or necessary
to make the statements therein (in the case of a prospectus, in the light of the circumstances under which they were made) not
misleading. Upon receipt of any written notice from FSD (which notice shall not contain any material non-public information regarding
FSD) of the happening of any of the foregoing or of a Suspension Event during the period that the Registration Statement is effective
or if as a result of a Suspension Event the Registration Statement or related prospectus contains any untrue statement of a material
fact or omits to state any material fact required to be stated therein or necessary to make the statements therein, in light of
the circumstances under which they were made (in the case of the prospectus) not misleading, the undersigned agrees that (1) it
will immediately discontinue offers and sales of the Shares under the Registration Statement (excluding, for the avoidance of doubt,
sales conducted pursuant to Rule 144) until the undersigned receives copies of a supplemental or amended prospectus (which FSD
agrees to promptly prepare) that corrects the misstatement(s) or omission(s) referred to above and receives notice that any post-effective
amendment has become effective or unless otherwise notified by FSD that it may resume such offers and sales, and (2) it will maintain
the confidentiality of any information included in such written notice delivered by FSD except (A) for disclosure to the Investor’s
employees, agents and professional advisers who need to know such information and are obligated to keep it confidential, (B) for
disclosures to the extent required in order to comply with reporting obligations to its limited partners who have agreed to keep
such information confidential and (C) as required by law or subpoena. FSD shall use its commercially reasonable efforts to
obtain the withdrawal of any order suspending the effectiveness of any Registration Statement as soon as reasonably practicable. Upon
the occurrence of any event contemplated in clauses (i) through (iv) above, except for such times as FSD is permitted hereunder
to suspend, and has suspended, the use of a prospectus forming part of a Registration Statement, FSD shall use its commercially
reasonable efforts to as soon as reasonably practicable prepare a post-effective amendment to such Registration Statement or a
supplement to the related prospectus, or file any other required document so that, as thereafter delivered to purchasers of the
Shares included therein, such prospectus will not include any untrue statement of a material fact or omit to state any material
fact necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading.

 

d. For
purposes of this Section 7, “Shares” shall mean, as of any date of determination, the Shares acquired by the Investor
pursuant to this Subscription Agreement and any other equity security issued or issuable with respect to such Shares by way of
share split, dividend, distribution, recapitalization, merger, exchange, replacement or similar event, and “Investor”
shall include any affiliate of the undersigned Investor to which the rights under this Section 7 shall have been duly assigned.

 

    8

     

    

 

e. FSD
shall indemnify the Investor (to the extent a seller under the Registration Statement), its officers, directors, partners, members,
managers, stockholders, advisers and agents, and each person who controls the Investor (within the meaning of Section 15 of the
Securities Act or Section 20 of the Exchange Act) to the fullest extent permitted by applicable law, from and against any and all
losses, claims, damages, liabilities, costs (including reasonable attorneys’ fees) and expenses (collectively, “Losses”),
as incurred, that arise out of or are based upon any untrue or alleged untrue statement of a material fact contained in the Registration
Statement (or incorporated by reference therein), any prospectus included in the Registration Statement or any form of prospectus
or in any amendment or supplement thereto or in any preliminary prospectus, or arising out of or relating to any omission or alleged
omission to state a material fact required to be stated therein or necessary to make the statements therein (in the case of any
prospectus or form of prospectus or supplement thereto, in light of the circumstances under which they were made) not misleading,
except to the extent, that such untrue statements or alleged untrue statements, omissions or alleged omissions are based upon information
regarding the Investor furnished in writing to FSD by the Investor expressly for use therein or Investor omitted a material fact
from such information.

 

f. Investor
shall indemnify and hold harmless FSD, its directors, officers, agents and employees, and each person who controls FSD (within
the meaning of Section 15 of the Securities Act and Section 20 of the Exchange Act), to the fullest extent permitted by applicable
law, from and against all Losses, as incurred, arising out of or are based upon any untrue or alleged untrue statement of a material
fact contained in any Registration Statement, any prospectus included in the Registration Statement, or any form of prospectus,
or in any amendment or supplement thereto or in any preliminary prospectus, or arising out of or relating to any omission or alleged
omission of a material fact required to be stated therein or necessary to make the statements therein (in the case of any prospectus,
or any form of prospectus or supplement thereto, in light of the circumstances under which they were made) not misleading to the
extent, but only to the extent, that such untrue statements or omissions are based upon information regarding the Investor furnished
in writing to FSD by the Investor expressly for use therein. In no event shall the liability of Investor exceed the net proceeds
received by the Investor upon the sale of the Shares giving rise to such indemnification obligation. The Investor shall notify
FSD promptly of the institution, threat or assertion of any proceeding arising from or in connection with the transactions contemplated
by this Section 7 of which the Investor is aware.

 

g. If
the indemnification provided under this Section 7 from the indemnifying party is unavailable or insufficient to hold harmless an
indemnified party in respect of any losses, claims, damages, liabilities and expenses referred to herein, then the indemnifying
party, in lieu of indemnifying the indemnified party, shall contribute to the amount paid or payable by the indemnified party as
a result of such losses, claims, damages, liabilities and expenses in such proportion as is appropriate to reflect the relative
fault of the indemnifying party and the indemnified party, as well as any other relevant equitable considerations. The relative
fault of the indemnifying party and indemnified party shall be determined by reference to, among other things, whether any action
in question, including any untrue or alleged untrue statement of a material fact or omission or alleged omission to state a material
fact, was made by, or relates to information supplied by, such indemnifying party or indemnified party, and the indemnifying party’s
and indemnified party’s relative intent, knowledge, access to information and opportunity to correct or prevent such action.
The amount paid or payable by a party as a result of the losses or other liabilities referred to above shall be subject to the
limitations set forth in this Section 7 and deemed to include any legal or other fees, charges or expenses reasonably incurred
by such party in connection with any investigation or proceeding. No person guilty of fraudulent misrepresentation (within the
meaning of Section 11(f) of the Securities Act) shall be entitled to contribution pursuant to this Section 7 from any person who
was not guilty of such fraudulent misrepresentation. Each indemnifying party’s obligation to make a contribution pursuant
to this Section 7(g) shall be individual, not joint and several, and in no event shall the liability of the Investor hereunder
exceed the net proceeds received by the Investor upon the sale of the Shares giving rise to such indemnification obligation.

 

8. Termination.
This Subscription Agreement shall terminate and be void and of no further force and effect, and all rights and obligations of
the parties hereunder shall terminate without any further liability on the part of any party in respect thereof, upon the
earlier to occur of (a) such date and time as the Transaction Agreement is terminated in accordance with its terms, (b) upon
the mutual written agreement of each of the parties hereto to terminate this Subscription Agreement, (c) if the consummation
of the Transaction has not occurred on or before May 15, 2021; or (d) if any of the conditions to Closing set forth in Section
3 of this Subscription Agreement are not satisfied or waived, or are not capable of being satisfied, on or prior to
the Closing and, as a result thereof, the transactions contemplated by this Subscription Agreement will not be and are not
consummated at the Closing; provided that nothing herein will relieve any party from liability for any
willful breach hereof prior to the time of termination, and each party will be entitled to any remedies at law or in equity
to recover losses, liabilities or damages arising from any such breach. FSD shall notify the Investor of the termination of
the Transaction Agreement promptly after the termination of such agreement.

 

    9

     

    

 

9. Trust
Account Waiver. The Investor hereby acknowledges that FSD has established a trust account (the “Trust Account”)
containing the proceeds of its initial public offering (the “IPO”) and from certain private placements occurring
simultaneously with the IPO (including interest accrued from time to time thereon) for the benefit of FSD’s public stockholders
and certain other parties (including the underwriters of the IPO). For and in consideration of FSD entering into this Subscription
Agreement, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Investor
hereby agrees that it does not now and shall not at any time hereafter have any right, title, interest or claim of any kind in
or to any assets held in the Trust Account, and shall not make any claim against the Trust Account, regardless of whether such
claim arises as a result of, in connection with or relating in any way to this Subscription Agreement or any other matter, and
regardless of whether such claim arises based on contract, tort, equity or any other theory of legal liability (any and all such
claims are collectively referred to hereafter as the “Released Claims”). The Investor hereby irrevocably waives
any Released Claims that it may have against the Trust Account now or in the future as a result of, or arising out of, any discussions,
contracts or agreements with FSD and will not seek recourse against the Trust Account for any reason whatsoever; provided, however,
that nothing in this Section 9 shall be deemed to limit the Investor’s right to distributions from the Trust Account in accordance
with FSD’s certificate of incorporation in respect of any redemptions by the Investor in respect of Shares acquired by any
means other than pursuant to this Subscription Agreement. Nothing in this Section 9 shall be deemed to limit the Investor’s
right, title, interest or claim to any monies held in the Trust Account by virtue of its record or beneficial ownership of Shares
currently outstanding on the date hereof, pursuant to a validly exercised redemption right with respect to any such Shares, except
to the extent that the Investor has otherwise agreed with FSD to not exercise such redemption right.

 

10. Miscellaneous.

 

a. Neither
this Subscription Agreement nor any rights that may accrue to the Investor hereunder (other than the Shares acquired hereunder,
if any) may be transferred or assigned other than an assignment to any fund or account managed by the same investment manager as
the Investor or an affiliate thereof.

 

b. FSD
may request from the Investor such additional information as FSD may deem necessary to evaluate the eligibility of the Investor
to acquire the Shares, and the Investor shall promptly provide such information as may reasonably be requested to the extent readily
available and to the extent consistent with its internal policies and procedures; provided, that, FSD agrees to keep any such information
provided by the Investor confidential. The Investor acknowledges that FSD may file a copy of this Subscription Agreement with the
SEC as an exhibit to a periodic report of FSD or a registration statement of FSD.

 

c. The
Investor acknowledges that FSD, the Placement Agents and others will rely on the acknowledgments, understandings, agreements, representations
and warranties contained in this Subscription Agreement. Prior to the Closing, the Investor agrees to promptly notify FSD and the
Placement Agents if any of the acknowledgments, understandings, agreements, representations and warranties set forth herein are
no longer accurate in any material respect (other than those acknowledgments, understandings, agreements, representations and warranties
qualified by materiality, in which case the Investor shall notify FSD and the Placement Agents if they are no longer accurate in
all respects).

 

d. FSD,
the Investor and the Placement Agents are each entitled to rely upon this Subscription Agreement and each is irrevocably authorized
to produce this Subscription Agreement or a copy hereof to any interested party in any administrative or legal proceeding or official
inquiry with respect to the matters covered hereby.

 

e. All
of the agreements, representations and warranties made by each party hereto in this Subscription Agreement shall survive the Closing.

 

f. This
Subscription Agreement may not be modified, waived or terminated except by an instrument in writing, signed by each of the parties
hereto. No failure or delay of either party in exercising any right or remedy hereunder shall operate as a waiver thereof, nor
shall any single or partial exercise of any such right or power, or any abandonment or discontinuance of steps to enforce such
right or power, or any course of conduct, preclude any other or further exercise thereof or the exercise of any other right or
power. The rights and remedies of the parties hereunder are cumulative and are not exclusive of any rights or remedies that they
would otherwise have hereunder.

 

    10

     

    

 

g. This
Subscription Agreement (including the schedule hereto) constitutes the entire agreement, and supersedes all other prior
agreements, understandings, representations and warranties, both written and oral, among the parties, with respect to the
subject matter hereof. This Subscription Agreement shall not confer any rights or remedies upon any person other than the
parties hereto, and their respective successor and assigns; provided that, as set forth in Sections
10(c) and 10(d) hereto, each Placement Agent shall be a third-party beneficiary to this
Subscription Agreement and shall be entitled to the rights and benefits hereunder and may enforce the provisions hereof as if
it were a party hereto. h. Except as otherwise provided herein, this Subscription Agreement shall be binding upon, and inure
to the benefit of the parties hereto and their heirs, executors, administrators, successors, legal representatives, and
permitted assigns, and the agreements, representations, warranties, covenants and acknowledgments contained herein shall be
deemed to be made by, and be binding upon, such heirs, executors, administrators, successors, legal representatives and
permitted assigns.

 

i. If
any provision of this Subscription Agreement shall be adjudicated by a court of competent jurisdiction to be invalid, illegal or
unenforceable, the validity, legality or enforceability of the remaining provisions of this Subscription Agreement shall not in
any way be affected or impaired thereby and shall continue in full force and effect.

 

j. This
Subscription Agreement may be executed in one or more counterparts (including by facsimile or electronic mail or in .pdf) and by
different parties in separate counterparts, with the same effect as if all parties hereto had signed the same document. All counterparts
so executed and delivered shall be construed together and shall constitute one and the same agreement.

 

k. The
parties hereto agree that irreparable damage would occur in the event that any of the provisions of this Subscription Agreement
were not performed in accordance with their specific terms or were otherwise breached. It is accordingly agreed that the parties
shall be entitled to an injunction or injunctions to prevent breaches of this Subscription Agreement, without posting a bond or
undertaking and without proof of damages, to enforce specifically the terms and provisions of this Subscription Agreement, this
being in addition to any other remedy to which such party is entitled at law, in equity, in contract, in tort or otherwise.

 

l. THE PARTIES
HERETO IRREVOCABLY SUBMIT TO THE EXCLUSIVE JURISDICTION OF THE UNITED STATES DISTRICT COURT FOR THE SOUTHERN DISTRICT OF NEW
YORK AND THE SUPREME COURT OF THE STATE OF NEW YORK SOLELY IN RESPECT OF THE INTERPRETATION AND ENFORCEMENT OF THE PROVISIONS
OF THIS SUBSCRIPTION AGREEMENT AND THE DOCUMENTS REFERRED TO IN THIS SUBSCRIPTION AGREEMENT AND IN RESPECT OF THE
TRANSACTIONS CONTEMPLATED HEREBY, AND HEREBY WAIVE, AND AGREE NOT TO ASSERT, AS A DEFENSE IN ANY ACTION, SUIT OR PROCEEDING
FOR INTERPRETATION OR ENFORCEMENT HEREOF OR ANY SUCH DOCUMENT THAT IS NOT SUBJECT THERETO OR THAT SUCH ACTION, SUIT OR
PROCEEDING MAY NOT BE BROUGHT OR IS NOT MAINTAINABLE IN SAID COURTS OR THAT VENUE THEREOF MAY NOT BE APPROPRIATE OR THAT THIS
SUBSCRIPTION AGREEMENT OR ANY SUCH DOCUMENT MAY NOT BE ENFORCED IN OR BY SUCH COURTS, AND THE PARTIES HERETO IRREVOCABLY
AGREE THAT ALL CLAIMS WITH RESPECT TO SUCH ACTION, SUIT OR PROCEEDING SHALL BE HEARD AND DETERMINED BY SUCH A NEW YORK STATE
OR FEDERAL COURT. THE PARTIES HEREBY CONSENT TO AND GRANT ANY SUCH COURT JURISDICTION OVER THE PERSON OF SUCH PARTIES AND
OVER THE SUBJECT MATTER OF SUCH DISPUTE AND AGREE THAT MAILING OF PROCESS OR OTHER PAPERS IN CONNECTION WITH SUCH ACTION,
SUIT OR PROCEEDING IN THE MANNER PROVIDED IN SECTION 10(m)OF THIS SUBSCRIPTION AGREEMENT OR IN SUCH OTHER MANNER AS
MAY BE PERMITTED BY LAW SHALL BE VALID AND SUFFICIENT SERVICE THEREOF. EACH PARTY ACKNOWLEDGES AND AGREES THAT ANY
CONTROVERSY WHICH MAY ARISE UNDER THIS SUBSCRIPTION AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY IS LIKELY TO INVOLVE
COMPLICATED AND DIFFICULT ISSUES, AND THEREFORE EACH SUCH PARTY HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY RIGHT SUCH
PARTY MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY LITIGATION DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS
SUBSCRIPTION AGREEMENT OR THE TRANSACTIONS CONTEMPLATED BY THIS SUBSCRIPTION AGREEMENT. EACH PARTY CERTIFIES AND ACKNOWLEDGES
THAT (I) NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER
PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER; (II) SUCH PARTY UNDERSTANDS AND HAS
CONSIDERED THE IMPLICATIONS OF THE FOREGOING WAIVER; (III) SUCH PARTY MAKES THE FOREGOING WAIVER VOLUNTARILY AND (IV) SUCH
PARTY HAS BEEN INDUCED TO ENTER INTO THIS SUBSCRIPTION AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVER AND CERTIFICATIONS
IN THIS SECTION 10(l).

 

    11

     

    

 

m. All
notices, requests, demands, claims, and other communications hereunder shall be in writing. Any notice, request, demand, claim,
or other communication hereunder shall be deemed duly given (i) when delivered personally to the recipient, (ii) when sent by electronic
mail, on the date of transmission to such recipient; provided, that such notice, request, demand, claim or other communication
is also sent to the recipient pursuant to clauses (i), (iii) or (iv) of this Section 10(m), (iii) one business day
after being sent to the recipient by reputable overnight courier service (charges prepaid), or (iv) five (5) business days after
being mailed to the recipient by certified or registered mail, return receipt requested and postage prepaid, and, in each case,
addressed to the intended recipient at its address specified on the signature page hereof or to such electronic mail address or
address as subsequently modified by written notice given in accordance with this Section 10(m). All communications
sent to FSD shall be sent to: FS Development Corp., 600 Montgomery Street, Suite 4500, San Francisco, California 94111, Attn: Jim
Tananbaum, email: jim@foresitecapital.com, with a copy to: White & Case LLP, 1221 Avenue of the Americas, New York, New York
10020, Attn: Joel L. Rubinstein, Esq., email: joel.rubinstein@whitecase.com.

 

11. Disclosure.
FSD shall, by 9:00 a.m., New York City time, on the first business day immediately following the date of this Subscription Agreement,
issue one or more press releases or furnish or file with the SEC a Current Report on Form 8-K (collectively, the “Disclosure
Document”) disclosing, to the extent not previously publicly disclosed, the transactions contemplated hereby, all material
terms of the Transaction and any other material, non-public information that FSD has provided to the Investor at any time prior
to the filing of the Disclosure Document. From and after the disclosure of the Disclosure Document, to the knowledge of FSD, the
Investor shall not be in possession of any material, non-public information received from FSD or any of its officers, directors
or employees. Notwithstanding the foregoing, FSD shall not publicly disclose the name of the Investor or any affiliate or investment
adviser of the Investor, or include the name of the Investor or any affiliate or investment adviser of the Investor in any press
release or in any filing with the SEC or any regulatory agency or trading market, without the prior written consent (including
by e-mail) of the Investor, except as required by the federal securities laws, rules or regulations, and to the extent such disclosure
is required by other laws, rules or regulations, at the request of the staff of the SEC or regulatory agency or under the NYSE
regulations, in which case FSD shall provide the Investor with prior written notice (including by e-mail) of such permitted disclosure,
and shall reasonably consult with the Investor regarding such disclosure.

 

12. Exculpation.
The Investor agrees that none of (i) any other investor pursuant to any Other Subscription Agreement (including the respective
controlling persons, officers, directors, partners, agents, or employees of any investor) or (ii) the Placement Agents, their respective
affiliates or any of their or their respective affiliates’ control persons, officers, directors or employees shall be liable
to the Investor for any action heretofore or hereafter taken or omitted to be taken by any of them in connection with the purchase
of the Shares.

 

[SIGNATURE PAGES FOLLOW]

 

    12

     

    

 

IN WITNESS WHEREOF,
the Investor has executed or caused this Subscription Agreement to be executed by its duly authorized representative as of the
date set forth below.

 

	Name of Investor:	State/Country of Formation or Domicile:
	 	 
	By: 	 	 	 
	 	 
	Name: 	 	 
	 	 
	Title:	 	 
	 	 
	Name in which Shares are to be registered (if different):	Date: ________, 2020
	 	 
	Investor’s EIN:	 
	 	 
	Business Address-Street:	Mailing Address-Street (if different):
	 	 
	City, State, Zip:	City, State, Zip:
	 	 
	Attn: 	 	 	Attn:	 
	 	 
	Telephone No.:	Telephone No.:
	 	 
	Facsimile No.:	Facsimile No.:
	 	 
	Number of Shares subscribed for:	 
	 	 
	Aggregate Subscription Amount:$	Price Per Share: $10
	 	 	 	 	 	 	 	 	 

You must pay the Subscription
Amount by wire transfer of United States dollars in immediately available funds to the account specified by FSD in the Closing
Notice.

 

    13

     

    

 

IN WITNESS WHEREOF,
FSD has accepted this Subscription Agreement as of the date set forth below.

 

	 	By:	       
	 	Name:
	 	Title:
	 	 
	Date:    , 2020	 

 

    14

     

    

 

SCHEDULE
A

 

ELIGIBILITY REPRESENTATIONS OF THE INVESTOR

 

		A.	QUALIFIED INSTITUTIONAL BUYER STATUS

		(Please	check the applicable subparagraphs):

 

		☐	We
are a “qualified institutional buyer” (as defined in Rule 144A under the Securities Act (a “QIB”)).

 

		B.	INSTITUTIONAL ACCREDITED INVESTOR STATUS

		(Please	check the applicable subparagraphs):

 

		1.	☐ We
are an “accredited investor” within the meaning of Rule 501(a) under the Securities Act or an entity in which all
of the equity holders are accredited investors within the meaning of Rule 501(a) under the Securities Act, and have marked and
initialed the appropriate box below indicating the provision under which we qualify as an “accredited investor.”

 

		2.	☐ We
are not a natural person.

 

Rule 501(a), in relevant part, states that an “accredited
investor” shall mean any person who comes within any of the below listed categories, or who the issuer reasonably believes
comes within any of the below listed categories, at the time of the sale of the securities to that person. The Investor has indicated,
by marking and initialing the appropriate box below, the provision(s) below which apply to the Investor and under which the Investor
accordingly qualifies as an “accredited investor.”

 

 ☐ Any bank, registered broker or dealer, insurance company, registered investment company, business development company, or small business investment company;

 

 ☐ Any plan established and maintained by a state, its political subdivisions, or any agency or instrumentality of a state or its political subdivisions for the benefit of its employees, if such plan has total assets in excess of $5,000,000;

 

 ☐ Any employee benefit plan, within the meaning of the Employee Retirement Income Security Act of 1974, if a bank, insurance company, or registered investment adviser makes the investment decisions, or if the plan has total assets in excess of $5,000,000;

 

 ☐ Any organization described in Section 501(c)(3) of the Internal Revenue Code, corporation, similar business trust, or partnership, not formed for the specific purpose of acquiring the securities offered, with total assets in excess of $5,000,000;

 

 ☐ Any trust with assets in excess of $5,000,000, not formed to acquire the securities offered, whose purchase is directed by a sophisticated person; or

 

 ☐ Any entity in which all of the equity owners are accredited investors meeting one or more of the above tests.

 

		C.	INSTITUTIONAL ACCOUNTS STATUS

 

		☐	We
are an “institutional account” (as defined in FINRA RULE 4512(c)).

 

		D.	ACCREDITED INVESTOR STATUS

 

		(Please	check the applicable subparagraphs):

 

		1.	☐ I
am an “accredited investor” within the meaning of Rule 501(a) under the Securities Act or an entity in which all of
the equity holders are accredited investors within the meaning of Rule 501(a) under the Securities Act, and have marked and initialed
the appropriate box below indicating the provision under which we qualify as an “accredited investor.”

 

		2.	☐ I
am a natural person.

 

    15

     

    

 

Rule 501(a), in relevant part, states that an “accredited
investor” shall mean any person who comes within any of the below listed categories, or who the issuer reasonably believes
comes within any of the below listed categories, at the time of the sale of the securities to that person. The Investor has indicated,
by marking and initialing the appropriate box below, the provision(s) below which apply to the Investor and under which the Investor
accordingly qualifies as an “accredited investor.”

 

☐ Any
director, executive officer, or general partner of the issuer of the securities being offered or sold, or any director, executive
officer, or general partner of a general partner of that issuer;

 

☐ Any
natural person whose individual net worth, or joint net worth with that person’s spouse, at the time of his purchase exceeds
$1,000,000. For purposes of calculating a natural person’s net worth: (a) the person’s primary residence must not
be included as an asset; (b) indebtedness secured by the person’s primary residence up to the estimated fair market value
of the primary residence must not be included as a liability (except that if the amount of such indebtedness outstanding at the
time of calculation exceeds the amount outstanding 60 days before such time, other than as a result of the acquisition of the
primary residence, the amount of such excess must be included as a liability); and (c) indebtedness that is secured by the person’s
primary residence in excess of the estimated fair market value of the residence must be included as a liability; or

 

☐ Any
natural person who had an individual income in excess of $200,000 in each of the two most recent years or joint income with that
person’s spouse in excess of $300,000 in each of those years and has a reasonable expectation of reaching the same income
level in the current year.

 

This page should be completed by the
Investor

and constitutes a part of the Subscription Agreement.

 

 

16

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00320-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00320-of-00352.parquet"}]]